Aldactone

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Spironolactone 100mg

Available from:

Pfizer New Zealand Limited

INN (International Name):

Spironolactone 100 mg

Dosage:

100 mg

Pharmaceutical form:

Film coated tablet

Composition:

Active: Spironolactone 100mg Excipient: Calcium sulfate dihydrate Peppermint 961149/701213 Hypromellose Macrogol 400 Magnesium stearate Maize starch Opaspray yellow M-1-6032B Povidone

Units in package:

Blister pack, 100 tablets

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Piramal Healthcare UK Limited

Therapeutic indications:

Essential hypertension; oedematous conditions including congestive cardiac failure, cirrhosis of the liver, (with or without ascites) and the nephrotic syndrome; diagnosis and treatment of primary aldosteronism, as adjunctive therapy in malignant hypertension; in diuretic induced hypokalaemia/hypomagnesaemia when other measures are considered inappropriate or inadequate; prophylaxis of hypokalaemia in patients taking digitalis when other measures are considered inadequate or inappropriate, hirsutism.

Product summary:

Package - Contents - Shelf Life: Blister pack, - 100 tablets - 60 months from date of manufacture stored at or below 30°C - Bottle, plastic, - 100 tablets - 60 months from date of manufacture stored at or below 30°C

Authorization date:

1969-12-31